Filing Details

Accession Number:
0001193805-15-000427
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-25 17:19:01
Reporting Period:
2015-03-25
Filing Date:
2015-03-25
Accepted Time:
2015-03-25 17:19:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1619087 Steadymed Ltd. STDY Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1009258 Deerfield Management Co 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
1010823 L.p. Mgmt Deerfield 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
1352546 E James Flynn 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
1354395 Deerfield Special Situations Fund, L.p. 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
1603333 Deerfield Private Design Fund Iii, L.p. 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
1610540 Deerfield Mgmt Iii, L.p. 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2015-03-25 265,089 $0.00 265,089 No 4 C Indirect Through Deerfield Private Design Fund III, L.P.
Ordinary Shares Acquisiton 2015-03-25 265,089 $0.00 265,089 No 4 C Indirect Through Deerfield Special Situations Fund, L.P.
Ordinary Shares Acquisiton 2015-03-25 179,115 $8.50 444,204 No 4 P Indirect Through Deerfield Private Design Fund III, L.P.
Ordinary Shares Acquisiton 2015-03-25 558,440 $8.50 823,529 No 4 P Indirect Through Deerfield Special Situations Fund, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect Through Deerfield Private Design Fund III, L.P.
No 4 C Indirect Through Deerfield Special Situations Fund, L.P.
No 4 P Indirect Through Deerfield Private Design Fund III, L.P.
No 4 P Indirect Through Deerfield Special Situations Fund, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Series E Preferred Stock Disposition 2015-03-25 34,205 $0.00 265,089 $0.00
Ordinary Shares Series E Preferred Stock Disposition 2015-03-25 34,205 $0.00 265,089 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series E Preferred Stock was convertible at any time into 7.75 of the Issuer's ordinary shares (on an adjusted basis, after giving effect to the 7.75-for-1 stock split effected by the Issuer on March 2, 2015). Shares of Series E Preferred Stock had no expiration date and automatically converted into shares of the Issuer's ordinary shares upon the closing of the Issuer's initial public offering of ordinary shares.
  2. This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. ("Fund III") and Deerfield Mgmt, L.P. is the general partner of Deerfield Special Situations Fund, L.P. (together with Fund III, the "Funds"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P.
  3. In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.